2022
DOI: 10.1080/17512433.2022.2074835
|View full text |Cite
|
Sign up to set email alerts
|

Splicing deregulation, microRNA and notch aberrations: fighting the three-headed dog to overcome drug resistance in malignant mesothelioma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 167 publications
0
6
0
Order By: Relevance
“…Moreover, KEGG analysis on RNA-seq data showed the dominant pathway is STAT3/NOTCH1 signaling pathway. Recent studies have revealed that the aberrant activation of STAT3/Notch1 signaling play a critical role in the interaction between cancer stemness and therapy resistance [23,24], targeting STAT3/Notch1 signaling may inhibit the development of cancer stemness and reverse platinum-based chemoresistance [25,26].…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, KEGG analysis on RNA-seq data showed the dominant pathway is STAT3/NOTCH1 signaling pathway. Recent studies have revealed that the aberrant activation of STAT3/Notch1 signaling play a critical role in the interaction between cancer stemness and therapy resistance [23,24], targeting STAT3/Notch1 signaling may inhibit the development of cancer stemness and reverse platinum-based chemoresistance [25,26].…”
Section: Discussionmentioning
confidence: 99%
“…In recent years, epigenetic modification has been widely studied. Existing evidence shows that epigenetic modification exists in various molecular biological processes, and it has a significant role in the occurrence and development of cancer 27 31 . As the more critical one, m 6 A RNA modification has also been shown to have an important direct relationship with cancers 32 36 .…”
Section: Discussionmentioning
confidence: 99%
“…The Notch signaling pathway also enriches CSCs and regulates the EMT program in multiple cancers, including breast and lung cancer, pancreatic ductal adenocarcinoma, and malignant mesothelioma. [151][152][153][154][155] A previous finding showed a change in EMT status in lung adenocarcinoma upon treatment with gefitinib. 156 Subsequent studies further confirmed that the EMT process resulted from the activation of Notch-1 signaling pathway and led to gefitinib-acquired resistance.…”
Section: Epigenetic Mechanismsmentioning
confidence: 95%